Table VII.

 Multivariate Analysis of BP Goal Attainment Among Hypertensive Patients During Follow‐Up Adjusting for Confounding Factors (n=18,694)

variable	odds ratio	95%confidence interval
Nonelderly patients	Reference
Elderly patients (≥65 y)	0.83a	0.77	0.90
Sex
Male	Reference
Female	1.05	0.98	1.11
Race
Caucasian	Reference
African American	0.67a	0.62	0.73
Hispanic	1.09	0.93	1.28
Others	1.04	0.84	1.30
Baseline BP
Systolic BP	0.98a	0.98	0.98
Diastolic BP	1.04a	1.04	1.04
Dyslipidemia	1.03	0.96	1.11
BMI at baseline
Nonobese (<30 kg/m²)	Reference
Obese (≥30 kg/m²)	0.84a	0.78	0.90
Smoking status at baseline
Never smoked	Reference
Former smoker	1.06	0.99	1.14
Current smoker	0.95	0.87	1.04
Complicated hypertension	0.79a	0.72	0.94
Treated with multiple antihypertensive medications	1.00	0.93	1.08
Initial prescription medication
Fixed‐dose Combination	Reference
ACEI	0.93	0.86	1.01
ARB	0.92	0.83	1.02
BB	1.04	0.91	1.19
CCB	1.06	0.87	1.29
Diuretics	1.25a	1.13	1.39

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, β‐blocker; BMI, body mass index, BP, blood pressure; CCB, calcium channel blocker. ^a P<.001